GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 200 mg/vial
Product details
Registration number: SIN14925P
Classification: Prescription Only
Active ingredients: GEMCITABINE HYDROCHLORIDE EQV GEMCITABINE
Strength: 200 mg/vial
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
ATC code: L01BC05
HSA approval date: 25 January 2016
Manufacturer(s): Fresenius Kabi Oncology Limited
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 200 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14925P
Classification: Prescription Only
What active ingredients and strength are recorded for GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 200 mg/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: GEMCITABINE HYDROCHLORIDE EQV GEMCITABINE
Strength: 200 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 200 mg/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 200 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 200 mg/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Fresenius Kabi Oncology Limited
Manufacturing country/countries: INDIA
Where can I look up GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 200 mg/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14925P or the exact product name GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 200 mg/vial. The general register link does not preselect this product.
What are the source dates for this GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 200 mg/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 200 mg/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14925P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)